重组人α-Synuclein蛋白; 重组小鼠α-Synuclein蛋白; 重组猴α-Synuclein蛋白; 重组人β-Synuclein蛋白; 重组人Tau441蛋白; 重组人Tau410蛋白; 重组人Tau412蛋白; 重组人Tau381蛋白; 重组人Tau383蛋白; 重组人Tau352蛋白; 重组人Tau K18蛋白; 重组人Tau K19蛋白; 重组人Tau-441蛋白; 重组人Plasma蛋白; 重组人Chymotrypsin蛋白; 重组人Haptoglobin蛋白; 重组人Myeloperoxidase蛋白; 重组人Apolipoprotein D (Apo-D)蛋白; 重组人Apolipoprotein J (Apo-J)蛋白; 重组人Serum Amyloid A (Apo-SAA)蛋白; 重组人Apolipoprotein A-I (ApoA-I)蛋白; 重组人NebuSelect™ Recombinant ApoE2蛋白; 重组人NebuSelect™ Recombinant ApoE3蛋白; 重组人NebuSelect™ Recombinant ApoE4蛋白; 重组人Calmodulin-1蛋白; 重组牛Calmodulin蛋白; 重组人CXCL12蛋白; 重组马Latherin蛋白; 重组猪Tubulin from Porcine Brain蛋白; 重组人ADRA2B蛋白; 重组人C3AR1蛋白; 重组人CCR7蛋白; 重组人EDNRA蛋白; 重组人Galr1蛋白; 重组人Gpr84蛋白; 重组人GRPR蛋白; 重组人Mrgprf蛋白; 重组人OPRD1蛋白; 重组人P2RY1蛋白; 重组人QRFPR蛋白; 重组人S1PR1蛋白; 重组人Taar1蛋白; 重组人GPR179蛋白; 重组人BDKRB2蛋白; 重组人C5AR1蛋白; 重组人CCR8蛋白; 重组人CXCR1蛋白; 重组人DRD2蛋白; 重组人EDNRB蛋白; 重组人HCAR2蛋白; 重组人NTSR1蛋白; 重组人OPRK1蛋白; 重组人PTAFR蛋白; 重组人Trhr蛋白; 重组人GPRC5D蛋白; 重组人ADRB1蛋白; 重组人Brs3蛋白; 重组人C5AR2蛋白; 重组人CCR9蛋白; 重组人CXCR2蛋白; 重组人DRD3蛋白; 重组人F2RL2蛋白; 重组人OPRL1蛋白; 重组人PTGDR蛋白; 重组人Rxfp3蛋白; 重组人ADRB2蛋白; 重组人CCKAR蛋白; 重组人CXCR3蛋白; 重组人DRD4蛋白; 重组人F2RL3蛋白; 重组人GHSR蛋白; 重组人HTR2B蛋白; 重组人PTGDR2蛋白; 重组人CCKBR蛋白; 重组人CXCR4蛋白; 重组人FFAR1蛋白; 重组人GNRHR蛋白; 重组人GPR35蛋白; 重组人HCRTR2蛋白; 重组人HTR2C蛋白; 重组人LPAR1蛋白; 重组人MC3R蛋白; 重组人Npbwr2蛋白; 重组人Ptger1蛋白; 重组人ADORA2A蛋白; 重组人AGTR1蛋白; 重组人CHRM2蛋白; 重组人CXCR5蛋白; 重组人HRH1蛋白; 重组人Lpar2蛋白; 重组人MC4R蛋白; 重组人NPFFR1蛋白; 重组人PTGER2蛋白; 重组人AGTR2蛋白; 重组人CHRM3蛋白; 重组人CXCR6蛋白; 重组人GPBAR1蛋白; 重组人LPAR3蛋白; 重组人NPFFR2蛋白; 重组人PTGER3蛋白; 重组人SSTR2蛋白; 重组人APLNR蛋白; 重组人Ccr2蛋白; 重组人Chrm4蛋白; 重组人GPR39蛋白; 重组人GPR75蛋白; 重组人Mchr1蛋白; 重组人Mtnr1B蛋白; 重组人PTGER4蛋白; 重组人SSTR3蛋白; 重组人GPRC5C蛋白; 重组人Ccr3蛋白; 重组人CHRM5蛋白; 重组人Cysltr2蛋白; 重组人FPR1蛋白; 重组人GPR146蛋白; 重组人NPY1R蛋白; 重组人SSTR4蛋白; 重组人TACR1蛋白; 重组人CCR4蛋白; 重组人CMKLR1蛋白; 重组人FPR2蛋白; 重组人HTR1A蛋白; 重组人Mlnr蛋白; 重组人SSTR5蛋白; 重组人SMO蛋白; 重组人AVPR2蛋白; 重组人CCR5蛋白; 重组人CNR1蛋白; 重组人Fpr3蛋白; 重组人HTR1B蛋白; 重组人Ltb4R蛋白; 重组人PPYR1蛋白; 重组人Prlhr蛋白; 重组人Sucnr1蛋白; 重组人TACR3蛋白; 重组人GCGR蛋白; 重组人FZD7蛋白; 重组人CCR6蛋白; 重组人Gpr52蛋白; 重组人Vipr2蛋白; 重组人CHRM1蛋白; 重组人DRD1蛋白; 重组人OPRM1蛋白; 重组人Htr1D蛋白; 重组人Htr1E蛋白; 重组人Htr2A蛋白; 重组人ADA2A蛋白; 重组人ADA2B蛋白; 重组人ADA2C蛋白; α-Synuclein protein; Synuclein protein; Alpha-Synuclein; Alpha Synuclein; SNCA; NACP; PARK1; β-Synuclein protein; Beta-Synuclein; Beta Synuclein; SNCB; Tau protein; MAPT; MTBT1; PHF-tau; p-Tau; NFT-tau; DDPAC; FTDP-17; Apo-E; APOE; SERPINA3; AACT; Alpha-1-antichymotrypsin; SERPINA1; AAT; Alpha-1 proteinase inhibitor (A1PI); A2M; α2M; Chymotrypsinogen; CT; Chymotrypsin A/B; HP; MPO; Fibrinolysin; PL; PLG; Plasminogen activator; TF; Siderophilin; APOD; CLU (Clusterin); Complement-associated protein SP-40; SAA; A-SAA (Acute-phase Serum Amyloid A); APOA1; Apo-AI; APOE ε2 (E2 isoform of Apolipoprotein E); APOE ε3 (E3 isoform of Apolipoprotein E); APOE ε4 (E4 isoform of Apolipoprotein E); CALM1; CaM; SDF-1; SDF1α/SDF1β; LATH; α/β-Tubulin heterodimer; ADRA2B; adrenergic; alpha-2B-; receptor; ADRA2L1; ADRA2RL1; alpha-2B adrenergic receptor; ADRARL1; alpha-2BAR; alpha-2B adrenoceptor; alpha-2B adrenoreceptor; G-protein coupled receptor; adrenergic receptor alpha 2B; alpha-2B-adrenergic receptor; alpha-2-adrenergic receptor-like 1; ADRA2B adrenergic; alpha-2 adrenergic receptor subtype C2; ALPHA2BAR,; C3AR1; complement component 3a receptor 1; C3a anaphylatoxin chemotactic receptor; AZ3B; C3AR; C3a-R; complement component 3 receptor 1; HNFAG09,; CCR7; chemokine (C-C motif) receptor 7; CMKBR7; EBI1; C-C chemokine receptor type 7; BLR2; CD197; CDw197; CCR-7; CC-CKR-7; C-C CKR-7; MIP-3 beta receptor; CC chemokine receptor 7; chemokine (C-C) receptor 7; Epstein-Barr virus induced gene 1; EBV-induced G protein-coupled receptor 1; EBV-induced G-protein coupled receptor 1; Epstein-Barr virus induced G-protein coupled receptor; lymphocyte-specific G protein-coupled peptide receptor; epstein-Barr virus-induced G-protein coupled receptor 1; CMKBR7,; EDNRA; endothelin receptor type A; endothelin-1 receptor; G protein-coupled receptor; endothelin receptor subtype A; endothelin-1-specific receptor; ETA; ET-A; ETAR; ETRA; ETA-R; hET-AR,; GALR1; GALNR; GALNR1; Galanin receptor type 1; GAL1-R; GALR-1; GPR84; EX33; G-protein coupled receptor 84; Inflammation-related G-protein coupled receptor EX33; PRH2; proline rich protein HaeIII subfamily 2; Pr; pr1/Pr2; PRP-1/PRP-2; salivary acidic proline-rich phosphoprotein 1/2; acidic salivary proline-rich protein; HaeIII type; 2; parotid acidic protein; parotid double-band protein; parotid proline-rich protein 1/2; protein C; MRGPRF; GPR140; GPR168; MRGF; PSEC0142; Mas-related G-protein coupled receptor member F; Mas-related gene F protein; G-protein coupled receptor 140; G-protein coupled receptor 168; OPRD1; opioid receptor; delta 1; delta-type opioid receptor; DOR-1; D-OR-1; delta opioid receptor 1; OPRD,; P2RY1; purinergic receptor P2Y; G-protein coupled; 1; P2Y purinoceptor 1; P2Y1; ATP receptor; platelet ADP receptor; P2 purinoceptor subtype Y1,; QRFPR; pyroglutamylated RFamide peptide receptor; G protein coupled receptor 103; GPR103; QRFP receptor; G protein-coupled receptor 103; G-protein coupled receptor 103; orexigenic neuropeptide QRFP receptor; AQ27; SP9155; MGC149217,; S1PR1; sphingosine-1-phosphate receptor 1; EDG1; endothelial differentiation; sphingolipid G protein coupled receptor; sphingosine 1-phosphate receptor 1; CD363; D1S3362; edg 1; S1P receptor 1; S1P receptor Edg-1; sphingosine 1-phosphate receptor EDG1; sphingosine 1-phosphate receptor Edg-1; endothelial differentiation G-protein coupled receptor 1; sphingolipid G-protein-coupled receptor; S1P1; ECGF1; EDG-1; CHEDG1; FLJ58121,; TAAR1; TA1; TAR1; TRAR1; Trace amine-associated receptor 1; TaR-1; Trace amine receptor 1; GPR179; G protein-coupled receptor 179; CSNB1E; GPR158L; GPR158L1; probable G-protein coupled receptor 179; GPR158-like 1; probable G-protein coupled receptor 158-like 1; BDKRB2; bradykinin receptor B2; B2 bradykinin receptor; BK 2; BK-2 receptor; B2R; BK2; BK-2; BKR2; BRB2; DKFZp686O088; C5AR1; complement component 5a receptor 1; C5R1; complement component 5 receptor 1 (C5a ligand); C5a anaphylatoxin chemotactic receptor; C5A; C5AR; CD88; C5a-R; C5a ligand; C5a anaphylatoxin receptor; complement component 5 receptor 1; C5R1,; CCR8; chemokine (C-C motif) receptor 8; CMKBR8; CMKBRL2; C-C chemokine receptor type 8; CDw198; CKR L1; CY6; GPR CY6; TER1; CC chemokine receptor 8; chemokine receptor-like 1; chemokine (C-C) receptor 8; CC chemokine receptor CHEMR1; CC-chemokine receptor chemr1; chemokine (C-C) receptor-like 2; CCR-8; CKRL1; GPRCY6; CC-CKR-8; MGC129966; MGC129973,; CXCR1; CD181; CDw128a; CKR 1; CXC-R1; CXCR-1; IL-8R A; C-C; CD128; CKR-1; IL8R1; IL8RA; CMKAR1; IL8RBA; C-C-CKR-1,; DRD2; dopamine receptor D2; D(2) dopamine receptor; dopamine D2 receptor; dopamine receptor D2 isoform; seven transmembrane helix receptor; D2R; D2DR,; EDNRB; endothelin receptor type B; HSCR; HSCR2; endothelin B receptor; ETB; endothelin receptor non-selective type; ET-B; ETBR; ETRB; WS4A; ABCDS; ET-BR; HSCR2,; HCAR2; hydroxycarboxylic acid receptor 2; G protein coupled receptor 109A; GPR109A; HCA2; HM74A; niacin receptor 1; NIACR1; Puma g; PUMAG; nicotinic acid receptor; G protein-coupled receptor 109A; G-protein coupled receptor 109A; G protein-coupled receptor HM74a; G-protein coupled receptor HM74A; hydroxy-carboxylic acid receptor 2; HM74b; Puma-g; GPR109A,; NTSR1; NTR1; OPRK1; kappa 1; kappa-type opioid receptor; KOR; KOR-1; K-OR-1; kappa opioid receptor; Opiate receptor; kappa-1; OPRK,; PAFR; PTAFR; TRHR; Thyrotropin-releasing hormone receptor; TRH-R; Thyroliberin receptor; GPRC5D; family C; group 5; member D; G-protein coupled receptor family C group 5 member D; orphan G-protein coupled receptor; MGC129713; MGC129714,; ADRB1; ADRB1R; RHR; B1AR; BETA1AR,; BRS3; Bombesin receptor subtype-3; BRS-3; C5AR2; G-protein coupled receptor 77; GPF77; GPR77; C5L2; G protein-coupled receptor 77; CCR9; chemokine (C-C motif) receptor 9; GPR28; C-C chemokine receptor type 9; CDw199; GPR 9 6; G protein-coupled receptor 28; GPR-9-6; CC-CKR-9,; CXCR2; chemokine (C-X-C motif) receptor 2; IL8RB; interleukin 8 receptor; beta; C-X-C chemokine receptor type 2; CD182; CMKAR2; CXC-R2; CXCR-2; IL-8R B; GRO/MGSA receptor; IL-8 receptor type 2; interleukin 8 receptor B; chemokine (CXC) receptor 2; interleukin 8 receptor type 2; interleukin-8 receptor type B; CXCR2 gene for IL8 receptor type B; high affinity interleukin-8 receptor B; IL8R2; CDw128b,; DRD3; dopamine receptor D3; D(3) dopamine receptor; essential tremor 1; dopamine D3 receptor; D3DR; ETM1; FET1; MGC149204; MGC149205,; F2RL2; coagulation factor II (thrombin) receptor-like 2; proteinase-activated receptor 3; PAR3; proteinase activated receptor 3; thrombin receptor-like 2; protease-activated receptor 3; proteinase-activated receptor-3; Coagulation factor II receptor-like 2 (protease-actovated receptor 3); PAR-3; FLJ51933,; OPRL1; opiate receptor-like 1; nociceptin receptor; kappa3 related opioid receptor; KOR 3; LC132 receptor like; NOCIR; OOR; ORL1; orphanin FQ receptor; kappa-type 3 opioid receptor; kappa3-related opioid receptor; KOR-3; MGC34578,; PTGDR; prostaglandin D2 receptor (DP); prostaglandin D2 receptor; DP; DP1; PTGDR1; PGD receptor; PGD2 receptor; AS1; ASRT1; MGC49004,; RXFP3; GPCR135; RLN3R1; SALPR; Relaxin-3 receptor 1; RLN3 receptor 1; G protein-coupled receptor SALPR; G-protein coupled receptor GPCR135; Relaxin family peptide receptor 3; Somatostatin- and angiotensin-like peptide receptor; N/A; CCKAR; cholecystokinin A receptor; cholecystokinin receptor type A; CCK-AR; CCK-A receptor; cholecystokinin-1 receptor; cholecystokinin type-A receptor; CCK-A; CCKRA; CCK1-R,; CXCR3; chemokine (C-X-C motif) receptor 3; G protein coupled receptor 9; GPR9; C-X-C chemokine receptor type 3; CD183; CKR L2; CMKAR3; IP10 R; MigR; CXC-R3; CXCR-3; Mig receptor; IP10 receptor; IP-10 receptor; G protein-coupled receptor 9; chemokine (C-X-C) receptor 3; interferon-inducible protein 10 receptor; Mig-R; CKR-L2; IP10-R,; DRD4; dopamine receptor D4; D(4) dopamine receptor; dopamine D4 receptor; D(2C) dopamine receptor; D4DR,; F2RL3; coagulation factor II (thrombin) receptor-like 3; proteinase-activated receptor 4; PAR4; proteinase activated receptor 4; PAR-4; thrombin receptor-like 3; protease-activated receptor-4; proteinase-activated receptor-4; coagulation factor II receptor-like 3,; GHSR; growth hormone secretagogue receptor; growth hormone secretagogue receptor type 1; GHRP; GHS-R; ghrelin receptor; GH-releasing peptide receptor,; HTR2B; 5-hydroxytryptamine (serotonin) receptor 2B; G protein-coupled; 5 hydroxytryptamine (serotonin) receptor 2B; 5-hydroxytryptamine receptor 2B; 5 HT(2B); 5 HT2B; 5-HT-2B; 5-HT 2B receptor; serotonin receptor 2B; 5-hydroxytryptamine 2B receptor; 5-hydroxytryptamine receptor 2B variant b; 5-HT2B; 5-HT(2B),; PTGDR2; prostaglandin D2 receptor 2; DP2; DL1R; CD294; CRTH2; GPR44; G-protein coupled receptor 44; chemoattractant receptor homologous molecule expressed on T helper type 2 cells; chemoattractant receptor-homologous molecule expressed on TH2 cells; putative G-protein coupled receptor 44; CCKBR; cholecystokinin B receptor; gastrin/cholecystokinin type B receptor; CCK-BR; CCK2-R; CCK2 receptor; CCK-B receptor; gastrin receptor; cholecystokinin-2 receptor; GASR; CCK-B; CCK2R,; FB22; HM89; LAP3; LCR1; NPYR; WHIM; CD184; LAP-3; LESTR; NPY3R; NPYRL; WHIMS; HSY3RR; NPYY3R; D2S201E; Fusin; Leukocyte-derived seven transmembrane domain receptor; Lipopolysaccharide-associated protein 3; FFAR1; free fatty acid receptor 1; G protein coupled receptor 40; GPR40; FFA1R; G protein-coupled receptor 40; G-protein coupled receptor 40; GPCR40,; GNRHR; gonadotropin-releasing hormone receptor; GRHR; LHRHR; gnRH-R; gnRH receptor; luliberin receptor; type I GnRH receptor; leutinizing-releasing hormone receptor; leutinizing hormone releasing horomone receptor; gonadotropin-releasing hormone (type 1) receptor 1; LRHR; GNRHR1,; GPR35; G protein-coupled receptor 35; G-protein coupled receptor 35; KYNA receptor; kynurenic acid receptor,; HCRTR2; hypocretin (orexin) receptor 2; orexin receptor type 2; OX2R; ox2-R; ox-2-R; hypocretin receptor type 2,; HTR2C; 5-hydroxytryptamine (serotonin) receptor 2C; 5 hydroxytryptamine (serotonin) receptor 2C; HTR1C; 5-hydroxytryptamine receptor 2C; 5 HT2C; 5-HT1C; 5-HT-1C; 5-HT-2C; serotonin receptor 2C; serotonin 5-HT-2C receptor; 5-hydroxytryptamine receptor 1C; 5-HT2C; 5-HTR2C,; LPAR1; lysophosphatidic acid receptor 1; EDG2; lysophosphatidic acid G protein coupled receptor; edg 2; Gpcr26; GPR26; LPA1; Mrec1.3; rec.1.3; vzg 1; LPA-1; LPA receptor 1; ventricular zone gene 1; lysophosphatidic acid receptor Edg-2; lysophosphatidic acid G-protein-coupled receptor; VZG1; edg-2; vzg-1,; MC3R; melanocortin 3 receptor; melanocortin receptor 3; MC3; Obesity quantitative trait locus; OB20; OQTL; BMIQ9; MC3-R,; NPBWR2; GPR8; Neuropeptides B/W receptor type 2; G-protein coupled receptor 8; PTGER1; Prostaglandin E2 receptor EP1 subtype; PGE receptor EP1 subtype; PGE2 receptor EP1 subtype; Prostanoid EP1 receptor; ADORA2A; adenosine A2a receptor; ADORA2; adenosine receptor A2a; RDC8; adenosine A2 receptor; adenosine receptor subtype A2a; hA2aR,; AGTR1; angiotensin II receptor; type 1; AGTR1B; angiotensin receptor 1B; type-1 angiotensin II receptor; AG2S; AGTR1A; AT1; AT1B; AT2R1; AT2R1A; AT2R1B; HAT1R; AT1AR; AT1BR; angiotensin receptor 1; angiotensin II type-1 receptor; type-1B angiotensin II receptor; AT1R; CHRM2; cholinergic receptor; muscarinic 2; muscarinic acetylcholine receptor M2; acetylcholine receptor; 7TM receptor; muscarinic M2 receptor; isoform a; HM2; FLJ43243; MGC120006; MGC120007,; CXCR5; chemokine (C-X-C motif) receptor 5; BLR1; Burkitt lymphoma receptor 1; GTP binding protein (chemokine (C X C motif) receptor 5); GTP binding protein; C-X-C chemokine receptor type 5; CD185; MDR15; CXC-R5; CXCR-5; MDR-15; monocyte-derived receptor 15; GTP-binding protein; GTP binding protein (chemokine (C-X-C motif) receptor 5); MGC117347,; HRH1; histamine receptor H1; histamine H1 receptor; H1R; HH1R; H1-R; hisH1,; LPAR2; EDG4; LPA2; Lysophosphatidic acid receptor 2; LPA receptor 2; LPA-2; Lysophosphatidic acid receptor Edg-4; NPTIIb; NAPI-3B; NAPI-Iib; SLC34A2; NPFFR1; neuropeptide FF receptor 1; G protein coupled receptor 147; GPR147; neuropeptide FF 1; NPFF1R1; OT7T022; G protein-coupled receptor 147; G-protein coupled receptor 147; RFamide-related peptide receptor OT7T022; NPFF1; FLJ10751,; PTGER2; prostaglandin E receptor 2 (subtype EP2); 53kDa; 53kD; prostaglandin E2 receptor EP2 subtype; EP2; prostanoid EP2 receptor; PGE receptor EP2 subtype; PGE2 receptor EP2 subtype,; AGTR2; type 2; angiotensin receptor 2; type-2 angiotensin II receptor; AT2; MRX88; angiotensin II type-2 receptor; ATGR2,; CHRM3; muscarinic 3; muscarinic acetylcholine receptor M3; m3 muscarinic receptor; HM3; EGBRS,; CXCR6; chemokine (C-X-C motif) receptor 6; C-X-C chemokine receptor type 6; BONZO; CD186; STRL33; TYMSTR; CDw186; CXC-R6; CXCR-6; G-protein coupled receptor bonzo; G-protein coupled receptor STRL33,; BG37; TGR5; M-BAR; GPCR19; GPR131; LPAR3; lysophosphatidic acid receptor 3; EDG7; 7; Edg 7; HOFNH30; LP A3; LPA3; RP4 678I3; LPA-3; LPA receptor 3; LPA receptor EDG7; lysophosphatidic acid receptor Edg-7; endothelial cell differentiation gene 7; calcium-mobilizing lysophosphatidic acid receptor LP-A3; GPCR; Edg-7; LP-A3; RP4-678I3; FLJ98231,; NPFFR2; neuropeptide FF receptor 2; G protein coupled receptor 74; GPR74; neuropeptide FF 2; NPFF2; NPGPR; G protein-coupled receptor 74; G-protein coupled receptor 74; G-protein coupled receptor HLWAR77; neuropeptide G-protein coupled receptor; HLWAR77,; PTGER3; prostaglandin E receptor 3 (subtype EP3); prostaglandin E2 receptor EP3 subtype; EP3; prostanoid EP3 receptor; PGE receptor; EP3 subtype; PGE2 receptor EP3 subtype; prostaglandin receptor (PGE-2); prostaglandin E receotor EP3 subtype 3 isoform; EP3e; EP3-I; EP3-II; EP3-IV; PGE2-R; EP3-III; MGC27302; MGC141828; MGC141829,; SSTR2; somatostatin receptor 2; SST2; somatostatin receptor type 2SRIF-1SS2R; APLNR; apelin receptor; AGTRL1; angiotensin II receptor like 1; APJ; APJ (apelin) receptor; APJR; FLJ90771; APJ receptor; HG11 orphan receptor; angiotensin receptor-like 1; G protein-coupled receptor APJ; G-protein coupled receptor APJ; angiotensin II receptor-like 1; G-protein coupled receptor HG11; HG11; FLJ96609; MGC45246,; CCR2; CMKBR2; C-C chemokine receptor type 2; C-C CKR-2; CC-CKR-2; CCR-2; Monocyte chemoattractant protein 1 receptor; MCP-1-R; CD antigen CD192; CHRM4; Muscarinic acetylcholine receptor M4; GPR39; G protein-coupled receptor 39; G-protein coupled receptor 39; GPR75; G protein-coupled receptor 75; probable G-protein coupled receptor 75; WI 31133; GPRchr2; WI31133; MGC132002,; MCHR1; GPR24; SLC1; Melanin-concentrating hormone receptor 1; MCH receptor 1; MCH-R1; MCHR-1; G-protein coupled receptor 24; MCH-1R; MCH1R; MCHR; SLC-1; Somatostatin receptor-like protein; MTNR1B; Melatonin receptor type 1B; Mel-1B-R; Mel1b receptor; PTGER4; prostaglandin E receptor 4; EP4; EP4R; prostaglandin E2 receptor EP4 subtype; EP4 subtype; PGE2 receptor EP4 subtype; prostaglandin E receptor 4 (subtype EP4); prostanoid EP4 receptor; SSTR3; somatostatin receptor 3; somatostatin receptor type 3; SS3R; SS3-R; SS-3-R; SSR-28,; GPRC5C; member C; G-protein coupled receptor family C group 5 member C; RAIG 3; retinoic acid-induced gene 3 protein; retinoic acid responsive gene protein; RAIG3; RAIG-3; MGC131820,; CCR3; CMKBR3; C-C chemokine receptor type 3; C C CKR3; C-C CKR-3; CC-CKR-3; CCR-3; CKR 3; CKR3; Eosinophil eotaxin receptor; CD antigen CD193; CHRM5; muscarinic 5; muscarinic acetylcholine receptor M5; HM5; MGC41838,; CYSLTR2; CYSLT2; CYSLT2R; PSEC0146; Cysteinyl leukotriene receptor 2; G-protein coupled receptor GPCR21; hGPCR21; G-protein coupled receptor HG57; HPN321; FPR1; formyl peptide receptor 1; fMet-Leu-Phe receptor; FMLP; FPR; fMLP receptor; N-formylpeptide chemoattractant receptor,; GPR146; G protein-coupled receptor 146; probable G-protein coupled receptor 146; PGR8; G protein-coupled receptor PGR8; G-protein coupled receptor PGR8,; NPY1R; neuropeptide Y receptor Y1; neuropeptide Y receptor type 1; NPY1-R,; SSTR4; somatostatin receptor 4; somatostatin receptor type 4; SS4R; SS4-R; SS-4-R,; TACR1; tachykinin receptor 1; TAC1R; substance-P receptor; NK1R; NKIR; SPR; NK-1R; NK-1 receptor; tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor),; CCR4; chemokine (C-C motif) receptor 4; C-C chemokine receptor type 4; CC CKR 4; CD194; ChemR13; CKR4; CMKBR4; k5 5; CCR-4; C-C CKR-4; chemokine (C-C) receptor 4; K5-5; CC-CKR-4; HGCN:14099; MGC88293,; CMKLR1; chemokine-like receptor 1; G-protein coupled receptor DEZ; G-protein coupled receptor ChemR23; Dez; ChemR23; CHEMERINR; MGC126105; MGC126106,; FPR2; formyl peptide receptor 2; formyl peptide receptor like 1; FPRL1; N-formyl peptide receptor 2; ALXR; FMLP R II; FMLPX; FPR2A; FPRH2; HM63; LXA4R; RFP; FMLP-R-I; LXA4 receptor; FMLP-related receptor I; formyl peptide receptor-like 1; lipoxin A4 receptor (formyl peptide receptor related); FPRH1; FMLP-R-II,; HTR1A; 5-hydroxytryptamine (serotonin) receptor 1A; 5 hydroxytryptamine (serotonin) receptor 1A; ADRB2RL1; ADRBRL1; 5-hydroxytryptamine receptor 1A; 5 HT1A; 5-HT1a receptor; serotonin receptor 1A; G protein coupled receptor; guanine nucleotide-binding regulatory protein-coupled receptor; G-21; 5HT1a; 5-HT1A; 5-HT-1A; ADRB2RL1,; MLNR; GPR38; MTLR; MTLR1; Motilin receptor; G-protein coupled receptor 38; SSTR5; somatostatin receptor 5; somatostatin receptor type 5; somatostatin receptor subtype 5; SS-5-R,; SMO; smoothened; frizzled family receptor; SMOH; smoothened (Drosophila) homolog; smoothened homolog (Drosophila); seven transmembrane spanning receptor; smoothened homolog; frizzled family member 11; FZD11; protein Gx; Gx; SMOH,; DI1; DIR; NDI; V2R; ADHR; DIR3; NDI1; CCR5; chemokine (C-C motif) receptor 5 (gene/pseudogene); chemokine (C C motif) receptor 5; CMKBR5; C-C chemokine receptor type 5; CC CKR 5; CD195; CKR 5; CKR5; IDDM22; HIV-1 fusion coreceptor; chemokine receptor CCR5; C-C motif chemokine receptor 5 A159A; CCR-5; CKR-5; CCCKR5; CC-CKR-5; FLJ78003,; CNR1; cannabinoid receptor 1 (brain); CNR; cannabinoid receptor 1; CANN6; CB R; CB1; CB1A; CB1K5; FPR3; FPRL2; N-formyl peptide receptor 3; FMLP-related receptor II; FMLP-R-II; Formyl peptide receptor-like 2; HTR1B; 5-hydroxytryptamine (serotonin) receptor 1B; 5 hydroxytryptamine (serotonin) receptor 1B; 5-hydroxytryptamine receptor 1B; 5 HT1B; 5 HT1DB; HTR1D2; S12; 5-HT-1B; 5-HT-1D-beta; serotonin receptor 1B; serotonin 1D beta receptor; 5-HT1B; HTR1DB; 5-HT1DB,; LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7; Leukotriene B4 receptor 1; LTB4-R 1; LTB4-R1; Chemoattractant receptor-like 1; G-protein coupled receptor 16; P2Y purinoceptor 7; P2Y7; PPYR1; pancreatic polypeptide receptor 1; neuropeptide Y receptor type 4; NPY4R; PP1; Y4; NPY4-R; MGC116897,; PRLHR; GPR10; GR3; Prolactin-releasing peptide receptor; PrRP receptor; PrRPR; G-protein coupled receptor 10; hGR3; SUCNR1; GPR91; Succinate receptor 1; G-protein coupled receptor 91; P2Y purinoceptor 1-like; TACR3; tachykinin receptor 3; neuromedin-K receptor; neurokinin beta receptor; NK3R; NK-3 receptor; neurokinin B receptor; NKR; NK-3R; TAC3RL; MGC148060; MGC148061,; GCGR; glucagon receptor; GGR; GL-R; FZD7; frizzled family receptor 7; frizzled (Drosophila) homolog 7; frizzled 7; frizzled homolog 7 (Drosophila); frizzled-7; FzE3; fz-7; hFz7; frizzled homolog 7; Frizzled; drosophila; homolog of; seven transmembrane spanning receptor,; CCR6; chemokine (C-C motif) receptor 6; STRL22; C-C chemokine receptor type 6; BN 1; CD196; CKR L3; CMKBR6; DCR2; DRY 6; GPR CY4; GPR29; LARC receptor; chemokine receptor-like 3; chemokine (C-C) receptor 6; G protein-coupled receptor 29; G-protein coupled receptor 29; seven-transmembrane receptor; lymphocyte; 22; BN-1; DRY6; CCR-6; CKRL3; CKR-L3; GPRCY4; CC-CKR-6; C-C CKR-6,; GPR52; G-protein coupled receptor 52; VIPR2; VIP2R; Vasoactive intestinal polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary adenylate cyclase-activating polypeptide type III receptor; PACAP type III receptor; PACAP-R-3; PACAP-R3; VPAC2; CD 182; CD182 antigen; CDw128b; CXCR 2; CXCR2_HUMAN; IL 8 receptor type 2; IL 8R B; IL-8 receptor; CXCR4; chemokine (C-X-C motif) receptor 4; chemokine (C X C motif); receptor 4 (fusin); C-X-C chemokine receptor type 4; CXC-R4; CXCR-4; CD184 antigen; SDF-1 receptor; neuropeptide Y receptor Y3; stromal cell-derived factor 1 receptor; seven-transmembrane-segment receptor; spleen; leukocyte-derived seven-transmembrane-domain receptor; NPYRL,; CHRM1; muscarinic 1; muscarinic acetylcholine receptor M1; M1; HM1; M1R; MGC30125,; DRD1; dopamine receptor D1; D(1A) dopamine receptor; dopamine D1 receptor; DADR; DRD1A,; D(4 dopamine receptor; D(2C dopamine receptor; OPRK; OPRM1; mu 1; mu-type opioid receptor; MOR1; MOP; hMOP; M-OR-1; mu opiate receptor; mu opioid receptor hMOR-1a; mu opioid receptor splice variant hMOR-1S; mu opioid receptor splice variant hMOR-1Z; mu opioid receptor splice variant hMOR-1b; mu opioid receptor splice variant hMOR-1Y2; mu opioid receptor splice variant hMOR-1Y3; MOR; LMOR; OPRM; KIAA0403,; HTR1D; HTR1DA; HTRL; 5-hydroxytryptamine receptor 1D; 5-HT-1D; 5-HT1D; Serotonin 1D alpha receptor; 5-HT-1D-alpha; Serotonin receptor 1D; HTR1E; 5-hydroxytryptamine receptor 1E; 5-HT-1E; 5-HT1E; S31; Serotonin receptor 1E; HTR2A; HTR2; 5-hydroxytryptamine receptor 2A; 5-HT-2; 5-HT-2A; Serotonin receptor 2A; 5-HTR2C; beta-1-; beta-1 adrenergic receptor; beta-1 adrenoceptor; beta-1 adrenoreceptor; ADRB2; ADRB2R; B2AR; Beta-2 adrenergic receptor; Beta-2 adrenoreceptor; Beta-2 adrenoceptor;  CD antigen CD294